Swiss Chinese Life Sciences Forum 2018
13:30 - 23:59
The Swiss Chinese Life Sciences Forum 2018 “Chinese Pharma Goes Global” September 13, 2018 / 13:30 – 17:30 plus Networking Apéro Novartis Campus, Basel The Chinese Pharma industry is rapidly upgrading its capabilities, moving from being a supplier of basic molecules and generics to becoming a major force in the development of innovative, molecular-targeted treatments and gene-based therapies. The Swiss Chinese Life Sciences Forum 2018 organised by BaselArea.swiss, the Fachhochschule Nordwestschweiz and the Swiss Chinese Chamber of Commerce and hosted by Novartis offers insights into key players in the Chinese Pharma landscape and identifies opportunities for greater collaboration between Swiss and Chinese Pharma. Key themes: Innovation in the Chinese Pharma Industry Internationalisation – Chinese Pharma companies go global China’s recent regulatory reform and the impact on innovation Swiss Pharma in China – the case of Novartis Collaboration between European and Chinese Life Sciences companies Expert Speakers include: John Oyler, CEO and Founder of BeiGene http://www.beigene.com Nigel Sheail - Head, Mergers & Acquisitions and Business Development & Licensing Novartis International AG, Basel www.novartis.com Bruno Delie - General Manager, Luye Supply AG http://www.luye-pharm.com/lvye_en/ Michael Frizberg - President CMAB Biopharma International http://www.cmabbio.com Larry Zhang - VP, Head of Public Affairs & CSR, Novartis China – Novartis Campus Shanghai Live Transmission www.novartis.com plus Asymchem http://www.asymchem.com.cn/ For details visit http://www.swiss-chinese-life-sciences-forum.ch
Sind Sie ein Veranstalter?
Die Veranstaltung wird interessierten Benutzern empfohlen.